Mainstream

Acme United anticipates sales growth in H2 2025 while expanding domestic production and managing tariff disruptions

Acme United anticipates sales growth in H2 2025 while expanding domestic production and managing tariff disruptions

Post ContentacuRead More

You might also be interested in reading Heron Therapeutics GAAP EPS of -$0.02 misses by $0.01, revenue of $37.2M misses by $0.88M.

July 23, 2025
In Mainstream